Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 24Lymphoma, Non-Hodgkin 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Large B-Cell, Diffuse 13Leukemia, Myeloid, Acute 9Leukemia 9Neuroblastoma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Central Nervous System Neoplasms 8Medulloblastoma 7Rhabdoid Tumor 6Recurrence 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Burkitt Lymphoma 6Neoplasms, Germ Cell and Embryonal 5Lymphoma, Follicular 5Lymphoma, B-Cell 5Glioma 5Brain Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Oligodendroglioma 4Neoplasms 4Lung Neoplasms 4Immunoblastic Lymphadenopathy 4Astrocytoma 4

Interventions

Paclitaxel 7Ifosfamide 7Cisplatin 5Filgrastim 4Etoposide 4Carboplatin 3pegfilgrastim 2Therapeutics 2Granulocyte Colony-Stimulating Factor 2Drug Therapy 2liposomal amphotericin B 1etoposide phosphate 1Vinblastine 1Thiotepa 1Sunitinib 1Ribavirin 1Radiotherapy 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1Oxaliplatin 1Nivolumab 1Mesna 1Lenograstim 1Itraconazole 1Interleukin-12 Subunit p35 1Interleukin-11 1Gemcitabine 1Fluconazole 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endodermal Sinus Tumor × etoposide phosphate × Clear all
NCT02375204 2025-01-13

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
420 enrolled

Nonseminomatous germ cell tumor, Choriocarcinoma, Neoplasms, Germ Cell and Embryonal, Teratoma, Germinoma, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡